Eventide Asset Management »

Aktis Oncology shares owned by Eventide Asset Management

Quarter-by-quarter ownership of Aktis Oncology shares owned by Eventide Asset Management from 13F filings

Historical chart of Eventide Asset Management investment in Aktis Oncology

Tip: Access up to 7 years of quarterly data

All positions including Aktis Oncology held by Eventide Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aktis Oncology by Eventide Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $9.1M 507k 17.89

More positions owned by Eventide Asset Management

Guardant Health (GH)
Trane Technologies SHS (TT)
Lam Research Corp Com New (LRCX)
Mirum Pharmaceuticals (MIRM)
Targa Res Corp (TRGP)
Xometry Class A Com (XMTR)
Ge Vernova (GEV)
Old Dominion Freight Line (ODFL)
Scholar Rock Hldg Corp (SRRK)
Argenx Se Sponsored Adr (ARGX)
Asml Hldg Nv N Y Registry Shs (ASML)
Irhythm Technologies (IRTC)
Insmed Com Par $.01 (INSM)
Axsome Therapeutics (AXSM)
Vaxcyte (PCVX)

View all positions for Eventide Asset Management

Top funds holding Aktis Oncology

MPM Oncology Impact Management
EcoR1 Capital
Wellington Management Company
BlackRock
RA Capital Management
Henderson Group
Baker Bros. Advisors
Octagon Capital Advisors
Merck & Co
Vanguard Capital Management
Eventide Asset Management
Geode Capital Management
Avidity Partners Management
State Street Corporation
AH Capital Management

View all funds holding Aktis Oncology